HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)
Condition(s):HIV-Associated Lipodystrophy Syndrome; Cardiovascular DiseaseLast Updated:April 12, 2012Completed
Hide Studies Not Open or Pending
Condition(s):HIV-Associated Lipodystrophy Syndrome; Cardiovascular DiseaseLast Updated:April 12, 2012Completed
Condition(s):HIV LipodystrophyLast Updated:January 27, 2016Completed
Condition(s):HIV Infections; HIV Lipodystrophy SyndromeLast Updated:November 15, 2005Terminated
Condition(s):HIV-Associated Lipodystrophy; HIV InfectionsLast Updated:April 2, 2009Terminated
Condition(s):HIV Lipodystrophy Syndrome; Growth Hormone Deficiency; Body CompositionLast Updated:October 26, 2022Recruiting
Condition(s):HIV/AIDS; HIV Lipodystrophy SyndromeLast Updated:August 21, 2015Completed
Condition(s):HIV Associated Lipodystrophy Syndrome.; HIV; Hypercholesterolemia; LipoatrophyLast Updated:September 5, 2005Completed
Condition(s):HIV-Associated Lipodystrophy Syndrome; Insulin Resistance; HIV Infections; Metabolic Syndrome X; Body Weight ChangesLast Updated:February 13, 2014Completed
Condition(s):HIV I Infection; HIV Associated Lipodystrophy; Metabolic Syndrome; AgingLast Updated:December 1, 2021Unknown status
Condition(s):HIV Infections; HIV-Associated Lipodystrophy Syndrome; HIV Lipodystrophy Syndrome; Lipodystrophy; Dyslipidemia; Osteoporosis; OsteopeniaLast Updated:January 7, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.